These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 4606455

  • 1. Drugs five years later: dextran 40.
    Data JL, Nies AS.
    Ann Intern Med; 1974 Oct; 81(4):500-4. PubMed ID: 4606455
    [No Abstract] [Full Text] [Related]

  • 2. Optimal molecular weight for the blood substitute polyglucin.
    Rozenberg GY, From AA, Polushina TV, Chernysheva EA, Lavrova RI.
    Fed Proc Transl Suppl; 1966 Oct; 25(5):805-8. PubMed ID: 5223564
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of shock with dextrans and gelatins. Effects and side effects.
    Lundsgaard-Hansen P.
    Vox Sang; 1969 Sep; 17(3):161-93. PubMed ID: 4187464
    [No Abstract] [Full Text] [Related]

  • 4. [Changes in some plasma parameters in the course of dextran 40].
    Bartolo M, Solitro A, Vaccaro E, Arcuri P, Altieri V.
    Minerva Med; 1975 May 12; 66(36):1704-19. PubMed ID: 1128815
    [Abstract] [Full Text] [Related]

  • 5. The uses of dextran in surgery: a current evaluation.
    Atik M.
    Surgery; 1969 Mar 12; 65(3):548-62. PubMed ID: 4885359
    [No Abstract] [Full Text] [Related]

  • 6. [Complications following dextran transfusion: their incidence and etiology].
    Kostrzewska E, Scharf R, Rudowski W, Ostrowska W.
    Pol Tyg Lek; 1973 Sep 17; 28(38):1477-80. PubMed ID: 4584269
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of low molecular weight (D-40) dextran on diuresis in extracorporeal perfusion].
    Antoszewski Z, Pietrzyk M, Woś S.
    Pol Przegl Chir; 1975 Nov 17; 47(11):1281-3. PubMed ID: 1197128
    [No Abstract] [Full Text] [Related]

  • 8. Renal toxicity of low molecular weight dextran: a review of the literature.
    Figueroa JE, Burgos-Calderon R.
    J La State Med Soc; 1974 Dec 17; 126(12):425-7. PubMed ID: 4436605
    [No Abstract] [Full Text] [Related]

  • 9. Low molecular weight dextran.
    Evarts CM.
    Med Clin North Am; 1967 Sep 17; 51(5):1285-99. PubMed ID: 4871552
    [No Abstract] [Full Text] [Related]

  • 10. [Intravascular disseminated coagulation syndrome during treatment with dextran 40].
    Wlodarczyk J, Kotschy M, Janukowiez-Lorenz H, Kurzawska M, Prastowski W, Rychlik W.
    Pol Tyg Lek; 1975 Feb 17; 30(7):297-9. PubMed ID: 1167691
    [No Abstract] [Full Text] [Related]

  • 11. Clinical aspects of dextran.
    Matheson NA.
    Acta Anaesthesiol Belg; 1968 Feb 17; 19(2):157-78. PubMed ID: 5746326
    [No Abstract] [Full Text] [Related]

  • 12. Intermittent low molecular weight dextran infusions in the management of ischemic skin disorders.
    Holti G.
    Bibl Anat; 1973 Feb 17; 11():359-63. PubMed ID: 4789063
    [No Abstract] [Full Text] [Related]

  • 13. [Prevention of thromboembolism with dextran].
    Gruber UF, Guardiola PM.
    Agressologie; 1983 Dec 17; 24(12):617-20. PubMed ID: 6199996
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Attempted evaluation of the rheological properties of dextran 40 "Polfa"].
    Kostrzewska E, Gregor A.
    Pol Tyg Lek; 1969 Jul 07; 24(27):1051-4. PubMed ID: 5805884
    [No Abstract] [Full Text] [Related]

  • 16. [Volume substitution with dextran].
    Gruber UF.
    Krankenpfl J; 1981 Dec 15; 19(12):19-21. PubMed ID: 6174774
    [No Abstract] [Full Text] [Related]

  • 17. The antithrombotic efficacy of dextran.
    Ljungström KG.
    Acta Chir Scand Suppl; 1988 Dec 15; 543():26-30. PubMed ID: 2461016
    [Abstract] [Full Text] [Related]

  • 18. Failure of low molecular weight dextran to prevent clotting during continuous renal replacement therapy.
    Palevsky PM, Burr R, Moreland L, Tokiwa Y, Greenberg A.
    ASAIO J; 1995 Dec 15; 41(4):847-9. PubMed ID: 8589465
    [Abstract] [Full Text] [Related]

  • 19. [Comparative evaluation of the effect of diuretics on kidney excretory function in patients operated on under artificial circulation and hemodilution].
    Tsyganiĭ AA, Stepanchuk MM, Andreev PG.
    Anesteziol Reanimatol; 1977 Dec 15; (6):74-8. PubMed ID: 341753
    [No Abstract] [Full Text] [Related]

  • 20. The influence of low molecular weight dextran on occlusive vascular disease.
    Fry WJ, Parker GW.
    Surg Gynecol Obstet; 1966 Sep 15; 123(3):531-4. PubMed ID: 5912865
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.